|
ZNF264 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.39349999999749E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.029700E-04 |
| Normal-vs-Stage2 |
3.718600E-03 |
| Normal-vs-Stage3 |
3.584700E-04 |
| Normal-vs-Stage4 |
3.58200000000197E-05 |
| Stage1-vs-Stage2 |
7.344000E-01 |
| Stage1-vs-Stage3 |
3.065200E-01 |
| Stage1-vs-Stage4 |
6.562000E-02 |
| Stage2-vs-Stage3 |
6.797600E-01 |
| Stage2-vs-Stage4 |
2.325400E-01 |
| Stage3-vs-Stage4 |
3.916200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.27569999999844E-05 |
| Normal-vs-AfricanAmerican |
1.405200E-01 |
| Normal-vs-Asian |
1.194060E-02 |
| Caucasian-vs-AfricanAmerican |
2.088000E-01 |
| Caucasian-vs-Asian |
3.104000E-01 |
| AfricanAmerican-vs-Asian |
6.190000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.359200E-03 |
| Normal-vs-Female |
4.87620000000355E-06 |
| Male-vs-Female |
2.443400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.177800E-04 |
| Normal-vs-Age(41-60Yrs) |
1.413670E-04 |
| Normal-vs-Age(61-80Yrs) |
3.3738000000394E-06 |
| Normal-vs-Age(81-100Yrs) |
6.616800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.070800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.059610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.624200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.921390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.228800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.772400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.986700E-04 |
| Classical-VS-Follicular |
1.295640E-02 |
| Classical-VS-Other |
4.304200E-01 |
| Classical-VS-Normal |
1.976700E-03 |
| Tall-VS-Follicular |
2.303800E-01 |
| Tall-VS-Other |
4.693000E-01 |
| Tall-VS-Normal |
2.24869999998489E-06 |
| Follicular-VS-Other |
9.753800E-01 |
| Follicular-VS-Normal |
2.25909999999052E-05 |
| Other-VS-Normal |
7.884400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.611520E-04 |
| Normal-vs-N1 |
1.027710E-04 |
| N0-vs-N1 |
3.346200E-01 |
|
|
